688670.SHG Jiangsu GDK Biotechnology Co Ltd

Healthcare Biotechnology Shanghai Stock Exchange
13.12 CNY
Close of Nov 5, 2026
11.67 31.20
Market cap
CNY 1.62B
P/E
-
P/B
1.44x
ROE
-9.7%
Dividend yield
0.08%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 688670.SHG undervalued?

Graham number

The Graham number of Jiangsu GDK Biotechnology Co Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Jiangsu GDK Biotechnology Co Ltd fundamental analysis

No fundamental analysis for Jiangsu GDK Biotechnology Co Ltd yet.

Jiangsu GDK Biotechnology Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Jiangsu GDK Biotechnology Co Ltd

Jiangsu Gdk Biological Technology Co., Ltd engages in the research, development, production, and sale of human vaccines. It offers quadrivalent influenza virus split vaccines. The company human vaccine products are used for the prevention of various infectious diseases, including influenza, rabies, chickenpox, shingles, and pneumonia. Jiangsu Gdk Biological Technology Co., Ltd was founded in 2008 and is based in Taizhou, China.

Full company profile